Improving waitlist and transplant outcomes by addressing symptoms and quality of life in liver transplant candidates and recipients

Dr. Rogal is a transplant hepatologist whose clinical research focuses on addressing the psychosocial contributions to quality of life and transplant outcomes.  She identified an association between untreated depression and increased post-transplant rejection and mortality.  Because depression is associated with pain and both conditions are often suboptimally managed in transplant populations, Dr. Rogal is currently developing and implementing a program to increase evidence-based management of these symptoms in the peri-transplant period.  Dr. Rogal also works in implementation science more broadly and has developed novel methods to assess the contributions of implementation strategies to the quality and equity of care.

Additional Research Areas:
Implentation science
Health equity research